Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.9 (102 reviews) Sold : Login>>
Novo Nordisk presents new Phase III data for next-gen amylin cagrilintide US$ 24.64 Min. order: 1 piece ★★★★★ 4.1 (240 reviews) Sold : Login>>
Subcutaneous Cagrilintide, Semaglutide Shows Significant Weight Loss in Type 2 Diabetes Trial US$ 22.58 Min. order: 1 piece ★★★★★ 4.0 (250 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.1 (151 reviews) Sold : Login>>
Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 22.44 Min. order: 1 piece ★★★★★ 4.0 (171 reviews) Sold : Login>>
Novo Nordisk's cagrilintide shows promise in Phase 3 trial | Alan Nafiev posted on the topic US$ 20.52 Min. order: 1 piece ★★★★★ 4.8 (85 reviews) Sold : Login>>